Clearstead Advisors’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$910 Buy
179
+174
+3,480% +$816 ﹤0.01% 2729
2026
Q1
$18 Hold
5
﹤0.01% 2220
2025
Q4
$24 Hold
5
﹤0.01% 2674
2025
Q3
$24 Hold
5
﹤0.01% 3017
2025
Q2
$13 Hold
5
﹤0.01% 2720
2025
Q1
$14 Hold
5
﹤0.01% 2185
2024
Q4
$20 Hold
5
﹤0.01% 2083
2024
Q3
$36 Hold
5
﹤0.01% 2018
2024
Q2
$37 Hold
5
﹤0.01% 2006
2024
Q1
$48 Hold
5
﹤0.01% 1521
2023
Q4
$36 Hold
5
﹤0.01% 1506
2023
Q3
$40 Hold
5
﹤0.01% 1465
2023
Q2
$28 Hold
5
﹤0.01% 1364
2023
Q1
$29 Hold
5
﹤0.01% 1363
2022
Q4
$35 Buy
+5
New +$51 ﹤0.01% 1297

Other funds holding MSOS

Clearstead Advisors's MSOS Position: Q2 2026 in Review

Clearstead Advisors increased its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 3,480% in Q2 2026, buying an estimated $816 and bringing the position to 179 shares worth $910. The position accounts for ﹤0.01% of the portfolio, ranked #2729.

Clearstead Advisors first reported a position in MSOS in Q4 2022 and has held it in 15 quarters since. 169 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • Clearstead Advisors held 179 shares of AdvisorShares Pure US Cannabis ETF worth $910 as of Q2 2026.
  • Clearstead Advisors bought 174 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $816.
  • AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2729 holding.
  • Clearstead Advisors first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2022 and has held it in 15 quarters since.
  • 169 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.